A strategy of idarucizumab for pericardial tamponade during perioperative period of atrial fibrillation ablation.

Xin ZhaoLi-Zhu ChenXin SuDe-Yong LongCai-Hua SangRong-Hui YuRi-Bo TangRong BaiNian LiuChen-Xi JiangSong-Nan LiXue-Yuan GuoWei WangXin DuJian-Zeng DongChang Sheng Ma

Published in: Pacing and clinical electrophysiology : PACE (2021)

The "wait and see" strategy of idarucizumab for acute pericardial tamponade during the perioperative period of catheter ablation for AF may be safe and feasible.

Keyphrases

catheter ablation
atrial fibrillation
left atrial
left atrial appendage
cardiac surgery
oral anticoagulants
patients undergoing
direct oral anticoagulants
liver failure
heart failure
acute kidney injury
percutaneous coronary intervention
drug induced
aortic dissection
acute respiratory distress syndrome